Xianjun Yu
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 43
- Cancer, Hypoxia, and Metabolism 36
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research 262
- Lung Cancer Research Studies 56
- Immunology top 0.5%
- Molecular Biology top 0.2%
- Epigenetics and DNA Methylation 48
- Pulmonary and Respiratory Medicine top 0.5%
-
- Neuroendocrine Tumor Research Advances 118
-
- Pancreatitis Pathology and Treatment 49
-
- Neuroblastoma Research and Treatments 46
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Cancer Letters (21 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (16 papers)Pancreatology (15 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xianjun Yu
522 papers receiving 21.4k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 6.5k
- Oncology 9.1k
- Immunology 4.0k
- Molecular Biology 9.9k
- Pulmonary and Respiratory Medicine 3.9k
Countries citing papers authored by Xianjun Yu
This map shows the geographic impact of Xianjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianjun Yu more than expected).
Fields of papers citing papers by Xianjun Yu
This network shows the impact of papers produced by Xianjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianjun Yu. The network helps show where Xianjun Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianjun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 12 | |
| 15 | 2022 | 1 | |
| 16 | Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectivesbreakdown → | 2022 | 151 |
| 17 | 2019 | 120 | |
| 18 | 2017 | 46 | |
| 19 | 2016 | 76 | |
| 20 | 2013 | 37 |
About Xianjun Yu
Xianjun Yu is a scholar working on Oncology, Cancer Research, Epidemiology, Immunology and Neurology, having authored 544 papers that have together received 21.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (262 papers), Neuroendocrine Tumor Research Advances (118 papers), Lung Cancer Research Studies (56 papers), Pancreatitis Pathology and Treatment (49 papers), Epigenetics and DNA Methylation (48 papers), Neuroblastoma Research and Treatments (46 papers), Cancer Genomics and Diagnostics (43 papers) and Cancer, Hypoxia, and Metabolism (36 papers). The work is most often cited by research in Cancer Research (6.5k citations), Oncology (9.1k citations), Immunology (4.0k citations), Molecular Biology (9.9k citations) and Pulmonary and Respiratory Medicine (3.9k citations). Xianjun Yu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jin Xu, Si Shi, Chen Liang, Jie Hua, Qingcai Meng, Quanxing Ni, Chen Liu, Guopei Luo, Liang Liu and Jiang Long. Their work appears in journals such as Cancer Letters, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Pancreatology, Acta Biochimica et Biophysica Sinica and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.